Back
Robert Half Vs. Janux Therapeutics Industry Stock Comparison
Sell
32
RHI
Robert Half
Last Price:
68.74
Seasonality Move:
6.47%
Sell
43
JANX
Janux Therapeutics
Last Price:
45.45
Seasonality Move:
8.69%
Sell
32
Robert Half (RHI)
is a Sell
Is Robert Half a Buy, Sell or Hold?
- The current Robert Half [RHI] share price is $70.40. The Score for RHI is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- RHI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $47.99. The Score for JANX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RHI Stock Price Chart
What is Robert Half's stock price today?
-
The Robert Half share price today is $70.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RHI is experiencing selling pressure, which indicates risk of future bearish movement.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $47.99
The current trend is moderately bearish and JANX is experiencing slight selling pressure.
RHI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.66 | Sell |
Relative Strength Index (14 RSI): | 41.37 | Sell |
Chaikin Money Flow: | -477110 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (69.63 - 71.15) | Buy |
Bollinger Bands (100): | (72.66 - 82.56) | Sell |
JANX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.44 | Buy |
Relative Strength Index (14 RSI): | 46.13 | Sell |
Chaikin Money Flow: | -166576 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.56 - 57.74) | Sell |
Bollinger Bands (100): | (12.73 - 49.75) | Buy |
RHI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 70.89 | Sell |
20-day SMA: | 70.42 | Sell |
50-day SMA: | 73.83 | Sell |
200-day SMA: | 77.38 | Sell |
8-day EMA: | 70.77 | Sell |
20-day EMA: | 71 | Sell |
50-day EMA: | 73.27 | Sell |
200-day EMA: | 76.85 | Sell |
JANX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.61 | Sell |
20-day SMA: | 52.95 | Sell |
50-day SMA: | 46.13 | Buy |
200-day SMA: | 20.35 | Buy |
8-day EMA: | 49.4 | Sell |
20-day EMA: | 50.62 | Sell |
50-day EMA: | 45.17 | Buy |
200-day EMA: | 26.75 | Buy |
Robert Half Earnings Growth & RHI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.89 per share, and an increase next year of $1.04 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.05 per share, an increase this year of $0.09 per share, and a decrease next year of $0.57 per share.
Robert Half Technical Analysis
May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Janux Therapeutics Technical Analysis
May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |